JPRN-C000000299已完成未知
Randomized trial of telmisartan and/or enalapril on renoprotective effects for patients of chronic renal diseases with hypertension. - Telmisartan, Enalapril vs Combination for Hypertension and Nephropathies: Intervensive Controlled trial.
Institute of Clinical Medicine, University of Tsukuba0 个研究点目标入组 150 人开始时间: 2005年12月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
Because there was little accumulation of the number of cases, this study was terminated.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with allergy for angiotensin converting enzyme-inhibitor or angiotensin receptor blocker, liver injury, or pregnancy. Patients who are inadequate to entry this study by physicians in charge.
研究者
相似试验
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190098Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190099Takimoto Rishu40
已完成
1 期
Combination therapy with immune-cell therapy and immune check point inhibitor.malignant tumorJPRN-jRCTc031210185Takimoto Rishu3
已完成
1 期
Clinical trial to evaluate the safety of Temsirolimus combined with Vincristine and Irinotecan in children with recurrent/refractory solid tumorschildhood recurrent/refractory solid malignant tumorsJPRN-UMIN000017453atural Center for Basic Research and Development, Hiroshima University3